-
Trauma to the thoracic cavity is responsible for approximately 10-25%
of all trauma-related deaths, with the majority of these deaths
occurring after arrival at the emergency department. The mortality for
isolated chest injury is relatively low (less than 5%); however, with
multiple organ system involvement, the mortality approaches 30%. This
article dissects the critical aspects of thoracic trauma and highlights
acute care management strategies.
-
When it comes to treating lipids in patients with heart disease, the mantra may be, The lower the LDL, the better. Data from the multicenter Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial indicate that aggressive reduction of atherogenic lipoproteins prevents progression of disease.
-
-
-
From October 2003 to Jan. 9, 2004, the Centers for Disease Control and Prevention received reports of 93 influenza-associated deaths among children younger than 18 years. The demands the annual flu season places on emergency department and urgent care facilities and the voracity of the current years epidemic have overwhelmed many physicians.
-
In February, the FDA approved a new monoclonal antibody for the treatment of metastatic colorectal cancer.
-
Long-term treatment with aspirin is associated with a progressive diminution in platelet sensitivity to the drug.
-
The common and increasing practice of opioid treatment for chronic pain is reviewed. Randomized trials support this therapy, however the risk benefit decision is complicated by new evidence of hazards making this practice more difficult.
-
The use of serum procalcitonin helps to differentiate bacterial from viral lower respiratory infections and may reduce the use of unnecessary antibiotics.
-
